Resistance to adefovir dipivoxil therapy associated with the selection of a mutation in the hepatitis B virus.

Angus P, Vaughan R, Xiong S, Yang H, Delaney W, Gibbs C, Brosgart C, Colledge D, Edwards R, Bartholomeusz A, Locarnini S.
Gastroenterology 2003; 125:292-297.

Lamivudine and famciclovir resistant hepatitis B virus associated with fatal hepatic failure.

Ayres A, Bartholomeusz A, Lau G, Lam K-C, Lee J-Y, Locarnini, S.
J Clin Virol 2003; 27:111-116.

Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing.

Birch C, Middleton T, Hales G, Cooper D, Law M, Crowe S, Hoy J, Emery S
J Acquir Immune Defic Syndr 2003; 32:57-61.

Detection of Varicella-Zoster virus in genital specimens using a multiplex polymerase chain reaction.

Birch CJ, Druce DD, Catton MC, MacGregor L, Reid T.
Sex Transm Infect 2003; 79:298-300.

Lamivudine resistant occult HBV: implications for Public Health.

Bowden S, Bartholomeusz A, Locarnini S.
J Hepatol 2003; 38:526-528

Infectious mononucleosis.

Charles PGP.
Aust Fam Physician 2003; 32:785-8.

Management of healthcare workers after occupational exposure to hepatitis C virus.

Charles PGP, Angus PW, Sasadeusz JJ, Grayson ML.
Med J Aust 2003; 179:153-157.

Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro.

Chen RY, Edwards R, Shaw T, Colledge D, Delaney WEIV, Isom H, Bowden S, Desmond P, Locarnini S.
Hepatology 2003; 37:27-35.

Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.

Chen RY, Bowden S, Desmond PV, Dean J, Locarnini SA.
J Gastroenterol Hepatol 2003; 18:630-637.

Studies of measles viruses circulating in Australia between 1999 and 2001 reveals a new genotype.

Chibo D, Riddell MA, Catton MG, Lyon M, Lum G, Birch CJ.
Virus Res 2003; 91:213-221.

Treatment of chronic hepatitis B: Current challenges and future directions.

Chin R, Locarnini S.
Rev Med Virol 2003; 13:255-272.

Victoria's response to SARS.

Clothier H, Charles P.
Vic Infect Dis Bull 2003; 6:26-28.

Prevalence and characterisation of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals.

Cooley L, Ayres A, Bartholomeusz A, Lewin S, Crowe S, Mijch A, Locarnini S, Sasadeusz J.
AIDS 2003; 17:1649-1657.

Measles – get vaccinated.

Counahan M, Tobin S, Andrews R, Robinson P, Chibo D, Riddell M.
Vic Infect Dis Bull 2003; Vol 6:33-34.

Decontamination and sterilization protocol used during re-use of cardiac electrophysiology catheters inactivates human immunodeficiency virus.

Druce JD, Russell JS, Birch CJ, Yates LA, Harper RW, Smolich JJ.
Infect Control Hosp Epidemiol 2003; 24:184-190.

New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B.

Feld J, Lee J-Y, Locarnini S.
Hepatology 2003; 38:545-553.

Ethics committees and guardianship legislation.

Fielding J, Kelly H.
Med J Aust 2003; 179:390.

Investigation of infection control practices and knowledge of hepatitis C among body-piercing practitioners.

Hellard M, Aitken C, Macintosh A, Ridge A, Bowden S.
Am J Infect Control 2003; 31:215-220.

Novel pharmacophore-based methods reveal gossypol as a reverse transcriptase inhibitor.

Keller PA, Birch C, Leach SP, Tyssen D, Griffith R.
J Mol Graph Model 2003; 21:365-373.

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

Klein C, Bock CT, Wedemeyer H, Wustefeld T, Locarnini S, Dienes HP.
Gastroenterology 2003; 125:9-18.

An assessment of the Roche Amplicor Chlamydia trachomatis/Neisseria gonorrhoeae multiplex PCR assay in routine diagnostic use on a variety of specimen types.

Leslie DE, Azzato F, Ryan N, Fyfe J.
Commun Dis Intell 2003; 27:373-379.

The hepatitis B virus and common mutants.

Locarnini S, McMillan J, Bartholomeusz A.
Semin Liver Dis 2003; 23:5-20.

Hepatitis B viral resistance: mechanisms and diagnosis.

Locarnini S.
J Hepatol 2003; 39 Suppl 1:S124-S132.

Australian Mycobacterium Reference Laboratory Network. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2001.

Lumb R, Bastian I, Dawson D, Gilpin C, Haverkort F, James G, Sievers A
Commun Dis Intell 2003; 27:173-180.

Rotavirus detection and characterization in outbreaks of gastroenteritis in aged-care facilities.

Marshall J, Botes J, Gorrie G, Boardman C, Gregory J, Griffith J, Hogg G, Dimitriadis A, Catton M, Bishop R.
J Clin Virol 2003; 28: 331-340.

The incidence and characteristics of Norwalk-like virus associated gastroenteritis.

Marshall JA, Hellard ME, Sinclair MI, Fairley CK, Cox BJ, Catton MG, Kelly H, Wright PJ.
J Med Virol 2003; 69:568-578.

Acute flaccid paralysis in Australian children.

Morris AM, Elliott EJ, D'Souza RM, Antony J, Kennett M, Longbottom H.
J Paediatr Child Health 2003; 39:22-26.

Dried venous blood samples for the detection and quantification of measles IgG using a commercial enzyme immunoassay.

Riddell MA, Byrnes GB, Leydon JA, Kelly HA.
Bull World Health Organ 2003; 81:701 – 707.

Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus.

Schilling R, Ijaz S, Davidoff M, Lee J-Y, Locarnini S, Williams R, Naoumov N.
J Virol 2003; 77:8882-8892.

Trans Activity of the norovirus Camberwell proteinase and cleavage of the N-terminal protein encoded by ORFI.

Seah EL, Marshall JA, Wright PJ.
J Virol 2003; 77:7150-7155.

Induction interferon and ribavirin for re-treatment of chronic hepatitis C patients unresponsive to interferon alone.

Sievert W, Batey R, Mollison L, Pianko S, McDonald J, Marinos G, Reed W, Warner S, Bowden DS, De Solom R, Bhatal P
Aliment Pharmacol Ther 2003; 17:1197-1204.

Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules.

Tallis GF, Ryan GM, Lambert SB, Bowden DS, McCaw R, Birch CJ, Moloney M, Carnie JA, Locarnini SA, Rouch GJ, Catton MG.
J Viral Hepat 2003; 10:234-239.

Annual report of the National Poliovirus Reference Laboratory, 2002.

Thorley B, Brussen KA, Stambos V, Kelly H.
Comm Dis Intell 2003; 27:352-356.

The successes and challenges for a developed country.

Thorley B, Wood N. Towards global poliomyelitis eradication.
J Paediatr Child Health 2003; 39:647-650.

Working towards a simple case definition for influenza surveillance.

Thursky K, Cordova S, Smith D, Kelly H.
J Clin Virol 2003; 27:170-179.

Evaluation of the Melbourne Metropolitan Locum Service as a sentinel site for influenza surveillance.

Turner J, Kelly H, Long S, Hawkins B, Adams J.
Vic Infect Dis Bull 2003; 6:54-56.

Establishing thresholds for influenza surveillance in Victoria.

Watts C, Andrews R, Druce J, Kelly H.
Aust NZ J Public Health 2003; 27:409-412.